# OptiMAx Will Test Whether SQ-LNS Incentivises Vaccination Uptake in Rural Chad and Niger, With a Cost Effectiveness Analysis. It Will Also Look at Whether Having Received SQ-LNS Before Becoming Malnourished Leads to Better Outcomes for Children Treated Under the OptiMA Protocol.

> **NCT07592260** · NA · RECRUITING · sponsor: **Alliance for International Medical Action** · enrollment: 20000 (estimated)

## Conditions studied

- Malnutrition Severe
- Vaccination

## Interventions

- **DIETARY_SUPPLEMENT:** small quantity lipid-based supplement (SQ-LNS)

## Key facts

- **NCT ID:** NCT07592260
- **Lead sponsor:** Alliance for International Medical Action
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 20000 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07592260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07592260, "OptiMAx Will Test Whether SQ-LNS Incentivises Vaccination Uptake in Rural Chad and Niger, With a Cost Effectiveness Analysis. It Will Also Look at Whether Having Received SQ-LNS Before Becoming Malnourished Leads to Better Outcomes for Children Treated Under the OptiMA Protocol.". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT07592260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*